BRAVE
NEW WORLD
particles. The idea was to target
the drug and avoid the side effects
of paclitaxel.
There were medical skeptics,
and others who questioned SoonShiong’s business practices as he
built his pharmaceutical empire.
He once settled a corporate case
out of court with his own brother.
His pride and salesmanship occasionally clash with scientific caution. The FDA once ordered him
to tone down promotional claims
about his nanotechnology standards. Early in his career, he touted
a diabetes treatment based on what
turned out to be only a temporary
success with a single patient.
But the FDA first approved the
Abraxane technique in 2005. Abraxane is now approv